Beta Bionics Inc [BBNX] stock prices are down -0.13% to $29.72 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The BBNX shares have gain 4.98% over the last week, with a monthly amount glided 13.26%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Goldman upgraded its rating to Buy on October 01, 2025, and kept the price target unchanged to $26. On June 16, 2025, Truist initiated with a Buy rating and assigned a price target of $26 on the stock. Lake Street started tracking the stock assigning a Buy rating and suggested a price target of $30 on June 12, 2025. Wolfe Research initiated its recommendation with an Outperform and recommended $20 as its price target on May 30, 2025. Goldman started tracking with a Neutral rating for this stock on May 30, 2025, and assigned it a price target of $16. In a note dated February 24, 2025, Stifel initiated a Buy rating and provided a target price of $25 on this stock.
The stock price of Beta Bionics Inc [BBNX] has been fluctuating between $8.89 and $32.71 over the past year. Currently, Wall Street analysts expect the stock to reach $31 within the next 12 months. Beta Bionics Inc [NASDAQ: BBNX] shares were valued at $29.72 at the most recent close of the market. An investor can expect a potential return of 4.31% based on the average BBNX price forecast.
Analyzing the BBNX fundamentals
The Beta Bionics Inc [NASDAQ:BBNX] reported sales of 88.57M for trailing twelve months, representing a surge of 63.14%. Gross Profit Margin for this corporation currently stands at 0.55% with Operating Profit Margin at -0.77%, Pretax Profit Margin comes in at -0.88%, and Net Profit Margin reading is -0.88%. To continue investigating profitability, this company’s Return on Assets is posted at -0.24, Equity is -0.32 and Total Capital is -0.23. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 29.03 points at the first support level, and at 28.34 for the second support level. However, for the 1st resistance point, the stock is sitting at 30.23, and for the 2nd resistance point, it is at 30.74.
Ratios To Look Out For
It’s worth pointing out that Beta Bionics Inc [NASDAQ:BBNX]’s Current Ratio is 10.64. Also, the Quick Ratio is 9.83, while the Cash Ratio stands at 1.52. Considering the valuation of this stock, the price to sales ratio is 14.77, the price to book ratio is 4.44.
Transactions by insiders
Recent insider trading involved Mark Hopman, Officer, that happened on Dec 04 ’25 when 2061.0 shares were purchased. Chief Product Officer, Mensinger Mike completed a deal on Dec 02 ’25 to sell 1063.0 shares. Meanwhile, Chief Financial Officer Feider Stephen sold 1427.0 shares on Dec 02 ’25.
